Merck & Co Inc (MRK)

Add to Watchlists
Create an Alert
Quickflows
82.46 -0.73  -0.88% NYSE Jan 20, 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All MRK News

News

View All Events

Events

Date Type Description
02/04/2021 Earnings Merck & Co Inc Fourth Quarter Earnings Result for 2020
02/04/2021 08:00 EST Misc Merck & Co Inc Fourth Quarter Earnings Conference Call for 2020
12/14/2020 Dividends Amount: 0.65, Declared Date: Nov 11 2020, Pay Date: Jan 08 2021
10/27/2020 08:00 EDT Misc Merck & Co Inc Third Quarter Earnings Conference Call for 2020
10/27/2020 Earnings Merck & Co Inc Third Quarter Earnings in 2020 Release
09/14/2020 Dividends Amount: 0.61, Declared Date: Jul 28 2020, Pay Date: Oct 07 2020
07/31/2020 08:00 EDT Misc Merck & Co Inc Second Quarter Earnings Conference Call for 2020
07/31/2020 Earnings Merck & Co Inc Second Quarter Earnings in 2020 Release
06/12/2020 Dividends Amount: 0.61, Declared Date: May 26 2020, Pay Date: Jul 07 2020
05/26/2020 09:00 EDT Misc Merck & Co Inc Annual General Meeting for 2019
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 47.35B
Total Expenses (TTM) 34.16B
Net Income (TTM) 11.52B

Balance Sheet View Statement

Total Assets (Quarterly) 89.80B
Total Liabilities (Quarterly) 60.53B
Shareholders Equity (Quarterly) 29.19B

Cash Flow Statement View Statement

Cash from Operations (TTM) 11.04B
Cash from Investing (TTM) -5.428B
Cash from Financing (TTM) -6.215B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.merck.com
  • Investor Relations URL: http://investors.merck.com/investors/default.aspx
  • HQ State/Province: New Jersey
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Value
  • Next Earnings Release: Feb. 04, 2021
  • Last Earnings Release: Oct. 27, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Dec. 14, 2020
  • Description: Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 82.46
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
XLV Health Care Select Sector SPDR® ETF 4.80%
VDIGX Vanguard Dividend Growth Inv 2.70%
VIVAX Vanguard Value Index Inv 1.44%
VTV Vanguard Value ETF 1.44%
FWWMX American Funds Washington Mutual 529-F-3 1.05%
IVV iShares Core S&P 500 ETF 0.66%
SPY SPDR® S&P 500 ETF Trust 0.65%
VFINX Vanguard 500 Index Investor 0.65%
VOO Vanguard S&P 500 ETF 0.65%
VINIX Vanguard Institutional Index I 0.65%
VSTSX Vanguard Total Stock Mkt Idx Instl Sel 0.54%
VTI Vanguard Total Stock Market ETF 0.54%

Comparables

Edit
MRNA Moderna Inc
JNJ Johnson & Johnson
LLY Eli Lilly and Co
PFE Pfizer Inc
ABBV AbbVie Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.